Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
37 studies found for:    10-N-N-122
Show Display Options
Rank Status Study
1 Completed Safety of H1N1 Influenza Vaccination in Pregnant Women
Conditions: Virus Diseases;   Respiratory Tract Infections;   Influenza;   Orthomyxoviridae Infections
Intervention: Biological: split-virion, non-adjuvanted H1N1 vaccine of 15 μg
2 Recruiting Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid
Intervention: Drug: CP-690,550
3 Completed Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder
Interventions: Drug: PNB01 fixed dose combination of pipamperone and citalopram;   Drug: Citalopram;   Drug: Pipamperone
4 Completed
Has Results
TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
Condition: Skin and Subcutaneous Tissue Bacterial Infections
Interventions: Drug: TR-701 FA;   Drug: Linezolid
5 Active, not recruiting Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Condition: Breast Cancer
Interventions: Drug: Placebo;   Drug: Denosumab
6 Completed
Has Results
The Effects Of Fx-1006A On Transthyretin Stabilization And Clinical Outcome Measures In Patients With V122I Or Wild-Type TTR Amyloid Cardiomyopathy
Condition: Cardiomyopathy
Intervention: Drug: Fx-1006A
7 Completed
Has Results
RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure;   Anemia;   Cardiovascular Disease;   Ventricular Dysfunction;   Congestive Heart Failure
Interventions: Drug: Darbepoetin alfa;   Drug: Placebo
8 Recruiting QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: QVA149;   Drug: Long acting B2 agonist (LABA) and inhaled corticosteroid (ICS)
9 Completed
Has Results
Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants
Conditions: Meningitis;   Meningococcal Infection
Interventions: Biological: MenACWY-CRM197;   Biological: DTaP (Diptheria, Tetanus, Pertussis) Vaccine;   Biological: Hib (Haemophilus influenza b) Vaccine;   Biological: IPV (Inactivated Polio Vaccine) Vaccine;   Biological: Pneumococcal conjugate Vaccine;   Biological: MMR (Measles, Mumps, and Rubella) Vaccine;   Biological: Varicella Vaccine;   Biological: Hepatitis A Virus
10 Recruiting Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Condition: Dyslipidemia
Interventions: Biological: Evolocumab (AMG 145);   Other: Placebo;   Drug: Effective statin therapy
11 Completed Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery
Condition: Prophylaxis of Venous Thromboembolic Events
Interventions: Drug: TB-402;   Drug: Rivaroxaban
12 Recruiting Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Condition: Atherosclerosis
Interventions: Drug: Canakinumab;   Drug: Placebo
13 Completed TroVax Renal Immunotherapy Survival Trial
Condition: Clear Cell Renal Carcinoma
Intervention: Biological: Trovax
14 Completed
Has Results
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
Conditions: Primary Hypercholesterolemia;   Dyslipidemia
Interventions: Drug: Pitavastatin;   Drug: Atorvastatin
15 Completed Effects of Oral Mucolytics on Tear Film and Ocular Surface
Condition: In the Present Study, we Investigated the Effects of Oral Ambroxol on Tear Film and Ocular Surface.
Intervention: Drug: Ambroxol hydrochloride (Mucopect®, 60 mg, Boehringer Ingelheim)
16 Completed Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures
Condition: Epilepsy
Interventions: Other: Placebo;   Drug: Brivaracetam
17 Completed
Has Results
Spiriva Observational Study Measuring Saint George's Respiratory Questionnaire (SGRQ) in Routine Medical Practice in Central & Eastern European Region
Condition: Pulmonary Disease, Chronic Obstructive
Intervention:
18 Completed
Has Results
Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ranolazine;   Drug: Placebo;   Behavioral: Diet;   Behavioral: Exercise
19 Completed Clinical Trial of Safety and Efficiency of New Dosage Schedule for Dietressa Drug in Treatment of Obese Patients
Condition: Obesity
Interventions: Drug: Dietressa;   Drug: Placebo
20 Completed Clinical Trial of Safety and Efficiency of Various Dosage Schedules for Dietressa Drug in Treatment of Obese Patients
Condition: Obesity
Interventions: Drug: Dietressa;   Device: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Indicates status has not been verified in more than two years